` OBI (Ondine Biomedical Inc) vs FTSE All Share Index Comparison - Alpha Spread

OBI
vs
FTSE All Share Index

Over the past 12 months, OBI has outperformed FTSE All Share Index, delivering a return of 11% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
OBI vs FTSE All Share Index

Loading

Performance Gap
OBI vs FTSE All Share Index

Loading
OBI
FTSE All Share Index
Difference

Performance By Year
OBI vs FTSE All Share Index

Loading
OBI
FTSE All Share Index
Add Stock

Competitors Performance
Ondine Biomedical Inc vs Peers

FTSE All Share Index
OBI
ABT
ISRG
BSX
SYK
Add Stock

Ondine Biomedical Inc
Glance View

Market Cap
41.4m GBX
Industry
Health Care

Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-12-06. The firm is focused on developing products that utilizes its light-activated technology, primarily for the healthcare-associated infection (HAI) market. Photodisinfection provides a spectrum of antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance. The company offers solution in Steriwave Nasal Decolonization (ND) and SurgENT. Steriwave ND provides a spectrum antimicrobial providing targeted decolonization. SurgENT is a tool for cleaning and irrigating the paranasal sinuses. The intrasinus balloon design directs irrigant circumferentially around the sinus walls, maintaining debridement pressure.

OBI Intrinsic Value
4.83 GBX
Overvaluation 53%
Intrinsic Value
Price
O
Back to Top